Introduction: Intraurethral instillation of 2% lignocaine hydrochloride is associated with discomfort and stinging sensation, especially to male patients. This study was aimed to determine whether slow instillation and cooled gel reduces this discomfort.
Large number of urological procedures and outpatient based rigid cystoscopy for lower urinary tract symptoms, follow up of urological malignancies, and removal of double J stent are performed using topical analgesia. Cocaine was reported as the first topical anesthetic agent for cystoscopy in 1884. 1, 2 Although intraurethral 2% lignocaine hydrochloride gel is usually adequate for most office procedures; some patients, especially males, complain of some extent of discomfort and a stinging sensation. 3 In females, because of the short female urethra, the efficacy of intraurethral anesthesia by numerous means of topical application is limited and difficult to standardize.
3
The objectives of this study were to determine whether slow instillation of gel reduces the initial discomfort; and procedural outcome of cooled lignocaine hydrochloride compared to that at room temperature.
MATERIALS AND METHODS
A prospective randomized study was done in Department of Urology at National Academy of Medical Sciences, Bir Hospital between April 2018 and August 2018. Consecutive 160 male patients undergoing rigid cystoscopy for different indications were included in the study. Patients with urethral pathology and those concurrently using analgesics for any cause were excluded. Informed consents were obtained from all patients. All cystoscopies were performed under oral antibiotic coverage with 500mg Ciprofloxacin given 15 minutes prior to procedure.
INTRODUCTION
40 patients where 10 ml of 2% lignocaine hydrochloride gel, cooled overnight in refrigerator at 4 0 C was instilled and set 2 comprising of 40 patients where 10 ml of 2% lignocaine hydrochloride gel at room temperature was instilled in the urethra. Instillation period was 10 seconds for both sets of patients. Similarly for the next 80 patients, set 3 comprised 40 randomized patients, whom the lignocaine hydrochloride at room temperature was instilled in the urethra over a period of 10 seconds. Set 4 comprised 40 patients where lignocaine hydrochloride at room temperature was instilled in the urethra over a period of 2 seconds.
Penis was compressed with a gauze loop for 5 minutes for the drug to take effect in all patients. During this period, patients were assessed using nongraphical visual analogue scale for discomfort felt during the instillation of gel. Zero on the scale meant no discomfort at all and 10 meant severe discomfort and stinging sensation. Rigid cystoscopy using 19 Fr. Karl Storz sheath and 30 degree rod lens was performed in all patients. At the end of the procedure, patients were again assessed using the same nongraphical visual analogue scale for discomfort felt during cystoscopy.
The student's t-test was used for analysis of results and expressed as mean ± standard deviation (SD). A p value of <0.05 was considered statistically significant.
RESULTS
A total number of 160 consecutive male patients undergoing rigid cystoscopy for various indications were included in the study. As shown in table 1, the first two sets were comparable by age (44.34 vs.46.21 years). Initial discomfort was significantly lower in patients where cooled lignocaine was used (p value <0.05). Although procedural discomfort was lesser in patients where cooled lignocaine was used, it was statistically not significant (p value >0.05). In the second part of the study, set 3 and set 4 were analyzed. The two sets were statistically comparable by age (41.69 vs. 44.34 years). Significant initial discomfort was perceived by patients who received the topical anesthetic over 2 seconds (p value 0.001). Although procedural discomfort was more in patients where lignocaine was instilled in 2 seconds, it was statistically not significant (p value >0.05). 
DISCUSSION
Outpatient cystoscopy is one of the most common procedure performed in urology practice and it is usually well tolerated. 4 Two percent lignocaine hydrochloride have been used as an intraurethral local anesthetic in urology practice since 1949. 5 It has a medium potency and a medium duration of action. Lignocaine hydrochloride is a lipid-soluble amide base capable of entering the hydrophobic components of neuronal cell membranes and preventing the transmembrane flow of sodium ions necessary for the initiation and propagation of nerve signal action potentials. 6 Studies have been done on different aspects of intraurethral instillation of lignocaine for men undergoing cystoscopy including concentration, volumes, exposure times and temperatures of the gel. Various literatures have reported that warming local anaesthetic solutions to temperatures close to core body temperature reduced the pain associated with their intradermal or subcutaneous injection. [7] [8] [9] [10] [11] [12] [13] [14] Authors have postulated that warming lignocaine possibly increases the speed of its action by causing a temperature-dependent shift in its pKa. 15 This alteration in the reaction equilibrium of the lignocaine hydrochloride solution makes more of the active form available to inhibit nerve impulse conduction before any noxious stimulus associated with delivery can be registered by nociceptors. 9, 12, 13, 16 However, some authors have argued that warming lignocaine does not reduce the pain sensation. [17] [18] [19] [20] Similarly, some authors have stated that cooling lignocaine reduces the pain sensation. 21, 22 They have postulated that this is a cryo-analgesic phenomenon relating to the temperature of the gel vehicle and its thermal effect on nociceptors. There is good evidence that reducing temperature leads to reduced nociceptor responsiveness 23, 24 and therefore a reduced perception of pain associated with anaesthetic delivery. This has also been challenged by few authors. 25 We analyzed discomfort felt during initial instillation of the gel and during procedure. Although discomfort was lesser in both the instances with cooled lignocaine, initial discomfort was significantly lesser. Khan et al 26 explained that in tubular organs such as the ureter, vagina, gut, salivary and bile ducts, and sacular organs such as the urinary bladder, the pain/discomfort caused by distension works through a purinergic mechanosensory transduction mechanism so reduction of shear stress can be done by slow administration of lignocaine. We have also demonstrated that discomfort is lower when lignocaine was administered over 10 seconds compared to over 2 seconds with significant reduction in initial discomfort.
CONCLUSIONS
During rigid cystoscopy, discomfort is the most common complaint of male patients. This discomfort can be reduced by slow instillation of 2 % lignocaine gel over duration of 10 seconds compare to 2 seconds. Furthermore, the discomfort can also be minimized by using 2% lignocaine hydrochloride gel cooled to 40 C. Though procedural discomfort was also reduced in slow instillation and cooled lignocaine gel usage, it was not statistically significant. Hence, further study, involving large population may be helpful.
